7.2
CVE-2026-20297
- EPSS 0.48%
- Veröffentlicht 15.07.2026 17:18:13
- Zuletzt bearbeitet 24.07.2026 18:17:00
- CVE-Watchlists
- Unerledigt
Path Traversal through 'explicit_appname' in the App Install REST Endpoint in Splunk Enterprise
In Splunk Enterprise versions below 10.4.1, 10.2.5, 10.0.8, 9.4.13, and 9.3.14, and Splunk Cloud Platform versions below 10.5.2605.0, 10.4.2604.6, 10.2.2510.18, and 10.1.2507.24, a user who holds a role that contains the `edit_local_apps` and `install_apps` capabilities could cause a legitimate app installation to write files outside the intended app directory, into `$SPLUNK_HOME/etc/` and its subdirectories.<br><br>The vulnerability is caused by a path traversal in the app installation workflow, which does not restrict the installation path to the intended app directory.
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
Splunk ≫ Splunk Cloud Platform Version >= 10.1.2507 < 10.1.2507.24
Splunk ≫ Splunk Cloud Platform Version >= 10.2.2510 < 10.2.2510.18
Splunk ≫ Splunk Cloud Platform Version >= 10.4.2604 < 10.4.2604.6
VulnDex Vulnerability Enrichment
| Typ | Quelle | Score | Percentile |
|---|---|---|---|
| EPSS | FIRST.org | 0.48% | 0.387 |
| Quelle | Base Score | Exploit Score | Impact Score | Vector String |
|---|---|---|---|---|
| Cisco PSIRT | 7.2 | 1.2 | 5.9 |
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
|
CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.
Für Zugriff zu Vulnerability Intelligence ist ein VulnDex Zugang erforderlich.
https://advisory.splunk.com/advisories/SVD-2026-0703